...
首页> 外文期刊>Journal of Organometallic Chemistry >Reprint of: Synthesis, characterization and radiolabeling of carborane-functionalized tetrazines for use in inverse electron demand Diels-Alder ligation reactions
【24h】

Reprint of: Synthesis, characterization and radiolabeling of carborane-functionalized tetrazines for use in inverse electron demand Diels-Alder ligation reactions

机译:转载:用于逆电子需求Diels-Alder连接反应的碳硼烷官能化四嗪的合成,表征和放射性标记

获取原文
获取原文并翻译 | 示例

摘要

Carborane-tetrazine derivatives were developed that can be used to enable boron clusters to bind specific targets in vivo using pretargeting strategies and bioorthogonal inverse electron demand Diels-Alder chemistry. Specifically, 1,12-dicarba-closo-dodecaborate-1-(4-(1,2,4,5-tetrazin-3-yl) phenyl) methanamide and 1,2-dicarba-closo-dodecaborate-1-(4-(1,2,4,5-tetrazin-3-yl) phenyl) methanamide were synthesized in 49% and 78% yield respectively, and X-ray structures of both compounds determined. The ortho-carborane derivative was converted to the corresponding nido-cluster under mild conditions, and the product successfully radiolabelled with I-125 and I-123. The carborane-tetrazines react rapidly and in quantitative yields with (E)-cyclooct-4-enol (TCO) via a [4 + 2] inverse-electron demand Diels-Alder type reaction, where the second order rate constant in acetonitrile for the iodinated cluster was 199 +/- 26 M(-1)s(-1). The labelled tetrazines were stable in solution for extended periods and they were shown to bind in vitro to H520 cells, labelled with a TCO-modified antibody. Imaging studies on the I-123-labeled carborane-tetrazine were performed in healthy mice, and demonstrated minimal loss of iodine in vivo and high uptake in the liver and gall bladder. The reported compounds offer an alternative means of developing targeted boron neutron capture therapy (BNCT) and boron-based molecular imaging agents. (C) 2015 Published by Elsevier B. V.
机译:开发了碳硼烷-四嗪衍生物,可使用预靶向策略和生物正交逆电子需求Diels-Alder化学方法,使硼簇在体内结合特定靶标。具体而言,1,12-二氨基十二碳十二烷基-1-(4-(1,2,4,5-四嗪-3-基)苯基)甲酰胺和1,2-二氨基十二碳十二烷基-1-(4分别以49%和78%的产率合成了-((1,2,4,5-四嗪-3-基)苯基)甲酰胺,并测定了两种化合物的X射线结构。在温和的条件下,将邻甲硼烷衍生物转化为相应的氨基簇,并将产物成功用I-125和I-123放射性标记。碳硼烷-四嗪通过[4 + 2]逆电子需量Diels-Alder型反应与(E)-环辛-4-烯醇(TCO)迅速定量反应,其中乙腈中的二阶速率常数碘化簇为199 +/- 26 M(-1)s(-1)。标记的四嗪在溶液中可长期稳定,并且显示出它们在体外与用TCO修饰的抗体标记的H520细胞结合。在健康小鼠中对I-123标记的甲硼烷-四嗪进行了影像学研究,结果表明,体内碘的损失极小,并且在肝脏和胆囊中的摄取量很高。报告的化合物提供了开发靶向硼中子俘获疗法(BNCT)和基于硼的分子成像剂的替代方法。 (C)2015由Elsevier B.V.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号